Page last updated: 2024-12-11
5,7,4'-trihydroxy-8-methoxyflavone
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4'-hydroxywogonin: from Verbena officinalis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 5322078 |
| CHEMBL ID | 245712 |
| SCHEMBL ID | 738981 |
| MeSH ID | M0246303 |
Synonyms (23)
| Synonym |
|---|
| 57096-02-3 |
| 4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methoxy- |
| 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methoxy-4h-1-benzopyran-4-one |
| 5,7,4'-trihydroxy-8-methoxyflavone |
| CHEMBL245712 |
| LMPK12111363 |
| 4'-hydroxywogonin |
| isoscutellarein 8-methyl ether |
| 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methoxychromen-4-one |
| SCHEMBL738981 |
| DTXSID80205713 |
| AKOS028108779 |
| bdbm50482097 |
| 4''-hydroxywogonin |
| 8-methoxyapigenin |
| f 36; isoscutellarein 8-methyl ether |
| XH173145 |
| CS-0017861 |
| HY-N1904 |
| 4 inverted exclamation marka-hydroxywogonin |
| AC-34656 |
| 4/'-hydroxywogonin |
| FS-10031 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (7)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID305359 | Inhibition of influenza A/Guizhou/54/89(H3N2) virus sialidase after 10 mins by fluorometric assay | 2007 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 17, Issue:3 | Anti-influenza virus activity of biflavonoids. |
| AID305360 | Inhibition of influenza B/Ibaraki/2/85 virus sialidase after 10 mins by fluorometric assay | 2007 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 17, Issue:3 | Anti-influenza virus activity of biflavonoids. |
| AID1191652 | Toxicity against mouse RAW264.7 cells at 30 uM after 24 hrs in absence of LPS by MTT assay | 2015 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5 | Anti-inflammatory activity of phenolic compounds from the whole plant of Scutellaria indica. |
| AID1191650 | Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production by Griess reaction based method | 2015 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5 | Anti-inflammatory activity of phenolic compounds from the whole plant of Scutellaria indica. |
| AID481717 | Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | 2010 | European journal of medicinal chemistry, May, Volume: 45, Issue:5 | QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. |
| AID1191651 | Toxicity against mouse RAW264.7 cells at 30 uM after 24 hrs in presence of LPS by MTT assay | 2015 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5 | Anti-inflammatory activity of phenolic compounds from the whole plant of Scutellaria indica. |
| AID305358 | Inhibition of influenza A/PR/8/34(H1N1) virus sialidase after 10 mins by fluorometric assay | 2007 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 17, Issue:3 | Anti-influenza virus activity of biflavonoids. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (12)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.06
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.06) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||